AFG
AZN icon

Albion Financial Group’s AstraZeneca AZN Stock Holding History

Albion Financial Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.3K Hold
181
– – ﹤0.01% 313
2026
Q1 		$35.7K Buy
181
+12
+7% +$2.31K ﹤0.01% 299
2025
Q4 		$31K Hold
169
– – ﹤0.01% 299
2025
Q3 		$25.9K Buy
169
+45
+36% +$6.81K ﹤0.01% 317
2025
Q2 		$17.3K Sell
124
-180
-59% -$25.2K ﹤0.01% 322
2025
Q1 		$44.7K Hold
304
– – ﹤0.01% 251
2024
Q4 		$39.8K Buy
304
+124
+69% +$17.4K ﹤0.01% 269
2024
Q3 		$28K Hold
180
– – ﹤0.01% 266
2024
Q2 		$28.1K Hold
180
– – ﹤0.01% 269
2024
Q1 		$24.4K Hold
180
– – ﹤0.01% 267
2023
Q4 		$24.2K Hold
180
– – ﹤0.01% 257
2023
Q3 		$24.4K Hold
180
– – ﹤0.01% 250
2023
Q2 		$25.8K Hold
180
– – ﹤0.01% 256
2023
Q1 		$25K Hold
180
– – ﹤0.01% 247
2022
Q4 		$24.4K Hold
180
– – ﹤0.01% 246
2022
Q3 		$20K Sell
180
-26
-13% -$3.3K ﹤0.01% 259
2022
Q2 		$27K Hold
206
– – ﹤0.01% 249
2022
Q1 		$27K Sell
206
-26
-11% -$3.12K ﹤0.01% 291
2021
Q4 		$27K Buy
232
+39
+20% +$4.59K ﹤0.01% 331
2021
Q3 		$23K Hold
193
– – ﹤0.01% 313
2021
Q2 		$23K Buy
+193
New +$21.2K ﹤0.01% 318
2020
Q4 		$20K Buy
+198
New +$21K ﹤0.01% 308
2014
Q2 		– Sell
-6,620
Closed -$430K – 192
2014
Q1 		$430K Buy
6,620
+225
+4% +$14.5K 0.08% 121
2013
Q4 		$380K Buy
6,395
+1,780
+39% +$96.7K 0.07% 121
2013
Q3 		$240K Buy
+4,615
New +$232K 0.05% 143

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Albion Financial Group's AZN Position: Q2 2026 in Review

Albion Financial Group held its AstraZeneca (AZN) position steady in Q2 2026 at 181 shares worth $34.3K. The position accounts for ﹤0.01% of the portfolio, ranked #313.

Albion Financial Group first reported a position in AZN in Q3 2013 and has held it in 25 quarters since. The position peaked at $430K in Q1 2014. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Albion Financial Group held 181 shares of AstraZeneca worth $34.3K as of Q2 2026.
  • Albion Financial Group left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up ﹤0.01% of Albion Financial Group's portfolio in Q2 2026, its #313 holding.
  • Albion Financial Group first reported a position in AstraZeneca in Q3 2013 and has held it in 25 quarters since.
  • Albion Financial Group's AstraZeneca position peaked at $430K in Q1 2014.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Albion Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.